Type: Research Project page: Access page Country: Denmark Synopsis: It is a national, binding collaboration on cancer research and treatment, and organised as a national center with a Governance Board, Steering Committee, Scientific Council, and Secretariat. The centre’s professional foundation is solid and differentiated as well as strongly anchored in regional- and university management systems
Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big Data DRUG Project type: Clinic Project target: Infectious Disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSIDAD CARLOS III DE MADRID Keywords: drug discovery; AI; diabetes; tuberculosis; oral drug; infectius disease; clinical trial Countries:...
Dates: 01/01/2019 31/03/2025 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) Keywords: liver cihrrosis; biomarker; clinical trial; ACLF; acute-on-chronic liver failure; OMICs; hepatology;...
Dates: 01/01/2021 31/12/2024 Topic: Tool Project type: Preclinic Medical Device Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.4.2. – Individual awareness and empowerment for self-management of health Participating agents: AARHUS UNIVERSITET Keywords: software; surgery; machine learning; endometriosis; uterus; app; OMICs; patient care Countries: Denmark; Hungary; UK; France; Latvia;...
Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Project type: Preclinic Clinic Project target: Digestive disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: HUMANITAS UNIVERSITY Keywords: bowel disease; biomarker; dermatitis; ulcerative colitis; liquid biopsy; OMICs; IMID Countries: Italy; Austria; Germany; UK; Netherlands; Belgium;...
Dates: 01/07/2021 30/06/2026 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITY COLLEGE DUBLIN; NATIONAL UNIVERSITY OF IRELAND; DUBLIN Keywords: psoriasis; arthritis; autoimmunity; skin; drug discovery; machine learning;...
Dates: 01/01/2020 30/06/2025 Topic: Biomarkes identification Project type: Preclinic Clinic Immunotherapy Project target: Infectious disease Endocrine disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA Keywords: HIV-1; infectious disease; RNA virus; gut; microbiome; biomarker; AIDS; inflammation;...
Dates: 01/02/2021 31/01/2025 Topic: Tool Project type: Medical Device Project target: Neurology Financing: H2020-EU.1.2. – EXCELLENT SCIENCE – Future and Emerging Technologies (FET) H2020-EU.1.2.1. – FET Open Participating agents: WATERFORD INSTITUTE OF TECHNOLOGY Keywords: RNA; epilepsy; AI; implant; therapeutic; tRNA; neurology; computer cells Countries: Ireland; Denmark; Cyprus; Finland Project page: Access page
Dates: 01/07/2018 30/06/2025 Topic: Biomarkers identification Project type: Clinic Project target: Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: KOBENHAVNS UNIVERSITET Keywords: Acrylamide; toxicity; children; women; prenatal; obstetric; robotic; neurology; nutrition; tumour; mutation; growth Countries: Denmark; Sweden Project page: Access page
Dates: 01/09/2016 31/08/2023 Topic: Biomarkers identification Project type: Preclinic Project target: Endocrine disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: LUNDS UNIVERSITET -HELSINGIN YLIOPISTO -ACADEMISCH ZIEKENHUIS GRONINGEN -ITA-SUOMEN YLIOPISTO -UNIVERSITY OF DUNDEE -THE UNIVERSITY OF EXETER -Istituto di Ricerche Farmacologiche Mario...